A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)

被引：2

作者：

Miura, S. ^{[1
]}

Hsia, T. ^{[2
]}

Hung, J. ^{[3
]}

Jung, H. A. ^{[4
]}

Shih, J. ^{[5
]}

Park, C. ^{[6
,7
]}

Lee, S. H. ^{[8
]}

Okamoto, T. ^{[9
]}

Ahn, H. K. ^{[10
]}

Lee, Y. C. ^{[11
]}

Sato, Y. ^{[12
]}

Lee, S. S. ^{[13
]}

Mascaux, C. ^{[14
]}

Daoud, H. ^{[15
]}

Maerten, A. ^{[15
]}

Popat, S. ^{[16
,17
]}

机构：

[1] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[2] China Med Univ, Dept Resp Therapy, Dept Internal Med, China Med Univ Hosp, Taichung, Taiwan

[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan

[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea

[5] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan

[6] Chonnam Natl Univ, Sch Med, Dept Internal Med, Hwasun, South Korea

[7] Hwasun Hosp, Hwasun, South Korea

[8] Kyung Hee Univ, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med,Med Ctr, Seoul, South Korea

[9] Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan

[10] Gachon Univ, Gil Med Ctr, Div Med Oncol, Incheon, South Korea

[11] Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Dept Internal Med,Chonbuk Natl Univ Hosp,Med Sch, Jeonju, South Korea

[12] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan

[13] Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea

[14] Strasbourg Univ, Strasbourg Univ Hosp, Dept Pulm, Strasbourg, France

[15] Boehringer Ingelheim Int Gmbh, Ingelheim, Germany

[16] Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London, England

[17] Inst Canc Res, London, England

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期

关键词：

D O I：

10.1016/j.jtho.2021.08.531

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P50.03

引用

页码：S1115 / S1116

页数：2

共 50 条

[21] Real-world long-term outcomes of advanced/metastatic NSCLC patients treated with EGFR TKIs in Nottinghamshire
Lopez-Escola, C.
Mengoli, K.
Sheikh, O.
Karim, S.
Sadiq, M.
[J]. LUNG CANCER, 2020, 139 : S62 - S62
[22] Encouragement to Submit Data of Clinical Response to EGFR-TKIs in Patients With Uncommon EGFR Mutations
Yatabe, Yasushi
Pao, William
Jett, James R.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) : 775 - 776
[23] Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations.
Ou, Sai-Hong Ignatius
Lin, Huamao Mark
Hong, Jin-Liern
Yin, Yu
Jin, Shu
Lin, Jianchang
Mehta, Minal
Nguyen, Danny
Neal, Joel W.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[24] Real-World Characteristics and Outcomes of Advanced NSCLC Patients with Exon 19 or 21 EGFR Mutations
Winfree, K.
Molife, C.
Peterson, P.
Chen, Y.
Visseren, C.
Beyrer, J.
Leusch, M.
Dimou, A.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S23 - S23
[25] Afatinib in patients with EGFR mutation-positive (EGFRm plus ) NSCLC harbouring uncommon mutations: Experience in 'Real-World' clinical practice
Maerten, Angela
Brueckl, Wolfgang
Laack, Eckhart
Hoffmann, Christopher
Zhou, Caicun
Wu, Yi-Long
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 160 - 160
[26] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
Xiong, Liwen
Cui, Shaohua
Ding, Jingyan
Sun, Yun
Zhang, Longfu
Zhao, Yizhuo
Gu, Aiqin
Chu, Tianqing
Wang, Huimin
Zhong, Hua
Ye, Xin
Gu, Yi
Zhang, Xin
Hu, Min
Jiang, Liyan
[J]. ONCOTARGET, 2017, 8 (38) : 63846 - 63856
[27] Monitoring Plasma EGFR Mutations during First Line Treatment with EGFR TKIs in NSCLC Patients
Mohorcic, Katja
Kern, Izidor
Janzic, Urska
Hitij, Nina Turnsek
Rot, Mitja
Cufer, Tanja
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S388 - S389
[28] FURTHER: A global study to evaluate furmonertinib in patients with EGFR mutant NSCLC including uncommon EGFR mutations
Le, Xiuning
Spira, Alexander
Gadgeel, Shirish
Yu, Yan
Zhao, Yanqiu
Cheng, Ying
Riess, Jonathan
Juan-Vidal, Oscar
Gao, Bo
Yoh, Kiyotaka
Forster, Martin
Kitazono, Satoru
Hayashi, Hidetoshi
Planchard, David
Jiang, Yong
Huang, Jack
Baio, Nichole
Kowanetz, Marcin
Wang, Shirley
Leung, William
Hsu, Jerry Y.
Wang, Jie
[J]. CANCER RESEARCH, 2024, 84 (07)
[29] No, EGFR TKIs Should Be Reserved for Patients With EGFR Mutations
Riely, Gregory J.
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 41 - +
[30] Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
Wei, Zhigang
Ye, Xin
Yang, Xia
Zheng, Aimin
Huang, Guanghui
Li, Wenhong
Wang, Jiao
Han, Xiaoying
Meng, Min
Ni, Yang
[J]. ONCOTARGET, 2017, 8 (34) : 56714 - 56725

← 1 2 3 4 5 →